Comprehensive analysis of highly purified CD271+ and CD271− cell populations from malignant melanomas and normal melanocytes revealed two divergent arms of neurotrophin signaling, which balance between proliferative cell cycle signals, survival and epigenetic rewiring on one hand, and apoptosis, senescence, and developmental triggers on the other hand. The gene discussed is NGFR; the disease is cancer.